Split-Thickness Segment to Dominate Europe Skin Graft Market during 2020–2028

According to a new market research study on “Europe Skin Graft Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Graft thickness, Equipment, Application, and End user,” is expected to reach US$ 494.53 million by 2028 from US$ 294.33 million in 2021. The market is estimated to grow at a CAGR of 7.7% from 2021 to 2028. The report provides trends prevailing in the Europe skin graft market along with the drivers and restraints pertaining to the market growth.Increasing prevalence of skin cancer and diabetes is the major factor driving the growth of the Europe skin graft market. However, alternatives for skin grafts hinders the growth of Europe skin graft market.

Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths in the first wave of COVID-19. Also, in second wave of COVID-19, the majority of the deaths were registered in these countries. Therefore, to control the spread of coronavirus, governments of various countries have implemented lockdown. Thus, it is having affected the medical services for various health conditions, and all the services were offered only for COVID-19 infected people. For instance, Mallinckrodt, a UK-based specialty pharmaceutical company will have to wait a bit longer for an FDA decision on its regenerative skin tissue therapy StrataGraft, as COVID-19 travel restrictions forced the delay of a manufacturing plant inspection. The countries with the highest estimated incidence rates of skin cancer in Europe were Switzerland, Norway and the Netherlands. However, the services for skin cancer treatment has reduced dramatically. In addition, various events for skin graft procedures, such as conferences, awareness campaigns, have been postponed. Furthermore, the trade for skin grafts has been reduced for the time being, which has resulted in a loss for various companies during this pandemic and forecasted year.

The market for skin graft market is segmented into product, graft thickness, equipment, application, end user and country. Based on product, the market is segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. In 2020, the autologous segment held the largest share of the market. Based on graft thickness, the market is divided into split-thickness, full-thickness and composite graft. In 2020, the split thickness segment held the largest share of the market. Based on equipment, the market is segmented into dermatome, general surgical instruments, consumables, and others. In 2020, the dermatome segment held the largest share of the market. Based on application, the market is segmented into burns, extensive wound, skin cancer, and others. In 2020, the burns segment held the largest share of the market. Based on end user, the market is segmented into ambulatory surgical centers, hospitals and dermatology clinics. In 2020, the hospitals segment held the largest share of the market. Similarly, based on country, the market is bifurcated into Germany, UK, France, Italy, Spain, Rest of Europe. Germany contributed a substantial share in 2020. 

AVITA Medical; B. Braun Melsungen AG; De Soutter Medical; Integra Life Sciences Corporation; MiMedx; Nouvag AG; Organogenesis Inc; Smith & Nephew; Tissue Regenix Group; Zimmer Biomet; are among the leading companies in the Europe skin graft market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2019, Smith and Nephew has acquired skin substitute manufacturer Osiris Therapeutics for US$ 660 million. This acquisition is expected to expand Smith and Nephew's portfolio in advanced wound management.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com